DE68924205T2 - 5-Sauerstoffhaltige HMG-Co-A Reduktase-Inhibitoren. - Google Patents

5-Sauerstoffhaltige HMG-Co-A Reduktase-Inhibitoren.

Info

Publication number
DE68924205T2
DE68924205T2 DE68924205T DE68924205T DE68924205T2 DE 68924205 T2 DE68924205 T2 DE 68924205T2 DE 68924205 T DE68924205 T DE 68924205T DE 68924205 T DE68924205 T DE 68924205T DE 68924205 T2 DE68924205 T2 DE 68924205T2
Authority
DE
Germany
Prior art keywords
hmg
reductase inhibitors
oxygenated
ring
singly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68924205T
Other languages
English (en)
Other versions
DE68924205D1 (de
Inventor
Mark E Duggan
George D Hartman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/250,646 external-priority patent/US4921974A/en
Priority claimed from US07/322,398 external-priority patent/US4963538A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE68924205D1 publication Critical patent/DE68924205D1/de
Publication of DE68924205T2 publication Critical patent/DE68924205T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE68924205T 1988-06-29 1989-06-22 5-Sauerstoffhaltige HMG-Co-A Reduktase-Inhibitoren. Expired - Fee Related DE68924205T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21301088A 1988-06-29 1988-06-29
US07/250,646 US4921974A (en) 1988-09-29 1988-09-29 Intermediates and processes in the preparation of 5-oxygenated HMG-COA reductase inhibitors
US07/322,398 US4963538A (en) 1988-06-29 1989-03-13 5-oxygenated HMG-CoA reductase inhibitors

Publications (2)

Publication Number Publication Date
DE68924205D1 DE68924205D1 (de) 1995-10-19
DE68924205T2 true DE68924205T2 (de) 1996-03-28

Family

ID=27395805

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68924205T Expired - Fee Related DE68924205T2 (de) 1988-06-29 1989-06-22 5-Sauerstoffhaltige HMG-Co-A Reduktase-Inhibitoren.

Country Status (14)

Country Link
EP (1) EP0349063B1 (de)
JP (1) JPH0253752A (de)
KR (1) KR910000694A (de)
AT (1) ATE127798T1 (de)
AU (1) AU619563B2 (de)
CA (1) CA1328876C (de)
DE (1) DE68924205T2 (de)
DK (1) DK319989A (de)
FI (1) FI893004A (de)
HU (1) HUT50803A (de)
IL (1) IL90781A0 (de)
NO (1) NO892677L (de)
NZ (1) NZ229671A (de)
PT (1) PT90958B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT88364A (pt) * 1987-09-02 1989-07-31 Merck & Co Inc Process for preparing novel hmg-coa reductase inhibitors
US5200549A (en) * 1988-11-14 1993-04-06 Hoffman-La Roche Inc. Antipsoriatic agents
US5073568A (en) * 1988-11-14 1991-12-17 Hoffmann-La Roche Inc. Antipsoriatic agents
CA2036962C (en) * 1990-02-26 1998-09-15 Ann E. Decamp Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one
US5059696A (en) * 1990-03-15 1991-10-22 Merck & Co., Inc. Processes and intermediates for the preparation of 5-oxygenated hmg-coa reductase inhibitors
MY106564A (en) * 1990-07-06 1995-06-30 Squibb & Sons Inc Sulfur-substituted mevinic acid derivatives.
US5286746A (en) * 1991-12-20 1994-02-15 E. R. Squibb & Sons, Inc. Sulfur-substituted mevinic acid derivatives
US5369123A (en) * 1992-10-09 1994-11-29 E. R. Squibb & Sons, Inc. Nitrogen-substituted mevinic acid derivatives useful as HMG-CoA reductase inhibitors
SI20159A (sl) * 1999-02-04 2000-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nov postopek za odstranitev sililoksi zaščitne skupine iz 4-sililoksi tetrahidro-piran-2-on-ov
SI21187A (sl) * 2002-03-26 2003-10-31 Krka, Tovarna Zdravil D.D., Novo Mesto Postopek za pripravo 4-oksitetrahidropiran-2-onov
EP3698797A1 (de) 2017-10-16 2020-08-26 Tsinghua University -inhibitor des mevalonsäurewegs und pharmazeutische zusammensetzung davon

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56150037A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Hydronaphthalene compound
JPS58188872A (ja) * 1982-04-26 1983-11-04 Suntory Ltd オクタヒドロナフタレン誘導体及びその製造法
JPS59186972A (ja) * 1983-03-09 1984-10-23 Suntory Ltd オクタヒドロナフタレン誘導体並びにその製造法
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors
PT88364A (pt) * 1987-09-02 1989-07-31 Merck & Co Inc Process for preparing novel hmg-coa reductase inhibitors

Also Published As

Publication number Publication date
EP0349063A3 (en) 1990-05-09
CA1328876C (en) 1994-04-26
EP0349063B1 (de) 1995-09-13
NZ229671A (en) 1991-11-26
HUT50803A (en) 1990-03-28
PT90958A (pt) 1989-12-29
IL90781A0 (en) 1990-01-18
EP0349063A2 (de) 1990-01-03
DK319989D0 (da) 1989-06-28
AU619563B2 (en) 1992-01-30
FI893004A (fi) 1989-12-30
NO892677L (no) 1990-01-02
FI893004A0 (fi) 1989-06-19
DE68924205D1 (de) 1995-10-19
JPH0253752A (ja) 1990-02-22
AU3711689A (en) 1990-01-04
ATE127798T1 (de) 1995-09-15
PT90958B (pt) 1994-11-30
KR910000694A (ko) 1991-01-30
DK319989A (da) 1990-01-02
NO892677D0 (no) 1989-06-27

Similar Documents

Publication Publication Date Title
ES2101960T3 (es) Lactamas benzo-condensadas.
ES2000842A6 (es) Un procedimiento para la preparacion de analogos semisinteticos de compactina y mevinolina
DK51087D0 (da) Antihypercholesterolaemiske forbindelser
DE68924205T2 (de) 5-Sauerstoffhaltige HMG-Co-A Reduktase-Inhibitoren.
ES2032229T3 (es) Inhibidores de proteasas benzamidicos.
DE69132435D1 (de) Inhibitoren retroviraler Proteasen
AU2623192A (en) Antifungal agent
ES2179254T3 (es) 1-poliarilpirazoles plaguicidas.
DE68904018T2 (de) Antihypercholesterolemische 4,5-diaryl-2-substituierte thioimidazole.
DE68905406T2 (de) Chinolin-verbindung.
FI932691A (fi) Nya benzyl- och benzhydrylalkoholer
YU127289A (sh) INHIBITORI 5-OKSIGENISANE HMG-CoA REDUKTAZE
ATE135352T1 (de) 3-keto-hmg-coa reduktase-inhibitoren
ATE138382T1 (de) Antitumor- und antivirale-verbindung
DE69112248D1 (de) Polyzyklische Farbstoffe.
FI911124A (fi) Nya pyridinderivat och foerfaranden foer deras syntetisering.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee